Robert Silverman, PhD, JD
CEO
Revere Pharmaceuticals
Dr. Silverman has a legal, business and medicinal chemistry background that spans over 25 years in Boston biotech. He is a founder and CEO/President of Sunflor Pharmaceuticals and Revere Pharmaceuticals, two oncology-focused biotech companies based in Boston. Previously, he was the General Counsel of Concert Pharmaceuticals from 2007 to 2017, helping the company become public in 2014. Before Concert, Dr. Silverman was Associate General Counsel at Millennium Pharmaceuticals (now Takeda) where he led the company’s chemical patent practice. Prior to Millennium, he served in various legal roles at Vertex Pharmaceuticals and FMC Corporation. Dr. Silverman started his career as a research chemist and is an inventor of over 20 US patents. Dr. Silverman serves as a Director of Social Capital Inc., a non-profit organization that serves communities in the greater Boston area. He received his BA degree from Lehigh University, his PhD from the U of New Mexico and did postdoctoral training in organic chemistry at Stanford University. He received his JD from Rutgers Law School.
Sessions
-
19-Jun-2026Business Development Fundamentals-Day 1 of 3
-
20-Jun-2026Business Development Fundamentals-Day 2 of 3
-
21-Jun-2026Business Development Fundamentals-Day 3 of 3
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}